This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Angela Ruban
CEO & Co-Founder at NeuroHagana Ltd
Speaker

Profile

Dr. Angela Ruban holds a Ph.D. in Clinical Pharmacology and has dedicated the past two decades to advancing drug development for Central Nervous System (CNS) disorders. Her scientific expertise lies in elucidating the mechanisms of glutamate excitotoxicity and in developing therapeutic strategies for neurotrauma.


Dr. Ruban gained extensive experience in the drug development process through her roles as Chief Scientific Officer at Braintact Ltd. and as a Scientific Advisor at Yeda, the Technology Transfer Unit of the Weizmann Institute of Science. In 2015, she was appointed Principal Investigator at the Faculty of Medicine, Tel Aviv University, where she led pioneering research in emergency treatments for neurotrauma and CNS deseas.


Her research has been supported by prestigious foundations, including the U.S. Department of Defense, the Israel Ministry of Defense, the Wings for Life Foundation, and the Israel Innovation Authority.


In 2023, Dr. Ruban founded NeuroHagana Ltd., an innovative Israeli biotech start-up developing the first injectable emergency treatment designed to address all types and severities of neurotrauma.